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Expansion of the glomerular mesangium at the expense of
glomerular capillary filtration surface area is a key mechanism
leading to progressive loss of renal function in diabetic nephrop-
athy 11]. Careful, precise analysis of mesangial changes may give
information about pathogenesis and prognosis, and provide an
index of the efficacy of therapeutic intervention [2, 31. Mesangial
volume density (V) is defined as the fractional volume of
mesangium relative to its containing glomerular volume. Debate
persists as to the most efficient and precise method of assessing
mesangial volume fraction. The majority of workers have sampled
three or more glomeruli at one randomly selected level within the
glomerulus [4—7], but using a single level could predispose to bias
in the estimate by sampling peripheral areas of the glomerulus
that are unrepresentative of the whole due to the arborization of
the mesangium [8]. The observed variation in the estimate of
mesangial volume fraction in individual glomeruli from the same
patient has led to the development of a sampling regime examin-
ing three or more levels from each of three glomeruli, in an
attempt to improve precision [9—11]. Such multiple level sampling
is laborious, placing great demands on technician time and
necessitating additional, expensive electron microscopy. Extra
time is also required for morphometric analysis of the micro-
graphs.
Using the multiple sampling technique as described by
and Gundersen [II], an analysis of the contribution of between
patient, between glomerulus and between level variance within
each glomerulus to the overall variability in the estimate of
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mesangial volume fraction was made. From these data, we set out
to define a precise but resource-efficient method of measuring
mesangium volume fraction and its component matrix in percu-
taneous renal biopsy specimens from patients with early diabetic
nephropathy who were enrolled into an on-going study comparing
the effects of antihypertensive therapies on renal structure and
function [12].
Methods
Biopsies from the first ten patients recruited to the study are the
subject of the current analysis and their clinical details are given in
Table 1. Mean arterial pressure was calculated as diastolic + 1/3
pulse pressure from three measurements taken using a random
zero sphygmomanometer on each of three separate occasions in
the two months prior to renal biopsy. Three timed overnight urine
collections were taken for measurement of albumin excretion rate
and GFR was estimated from the plasma disappearance curves
following a bolus injection of 51Cr EDTA [13]. Renal biopsy was
performed under local anaesthetic using ultrasound guidance.
Biopsy specimens were fixed by immediate immersion in 2%
glutaraldehyde in modified phosphate buffer before transporta-
tion. 1 mm3 blocks of fixed tissue were embedded in coffin moulds
using a TAAB Premix Kit (medium) T028 resin (TAAB, Alder-
maston, Berkshire, UK). Each glomerulus within a block is
randomly orientated with respect to the plane of sectioning.
Semithin sections were taken through the tissue block at 10 jim
intervals and stained with 1% toluidine blue. Open, non-selerosed
glomeruli were identified using light microscopy and the first three
were systematically sampled by taking ultrathin sections at 50 jim
intervals. Three to five sections through each glomerulus were
obtained, depending upon glomerular size (Fig. 1). After staining
with uranyl acetate and lead citrate, ultrathin sections were
photographed using a Philips CM 100 electron microscope at low
and high magnification. The glomerular profile was photographed
by systematically moving the specimen stage controls. The result-
ing overlapping micrographs were pieced together to form a
montage of the glomerular cross-section at a final print magnifi-
cation of x2000. High power micrographs were taken by entering
the glomerulus randomly and systematically sampling approxi-
mately 25 to 30% of the glomerular tuft area [6]. Micrographs
were printed at a final print magnification of xiO,000. This
sampling procedure was followed regardless of the size of the
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Table 1. Clinical characteristics of 10 insulin-dependent diabetic
patients with albuminuria
Number (M/F) 10 (5/5)
Age years (mean, range) 37 20—57
Diabetes duration years (mean, range) 24 7—43
Mean arterial pressure mm Hg (mean, range) 91 76-101
Albumin excretion rate jig/mm (median, range)





Mesangial V., (mean, SD) 0.39 0.108
Matrix V. (mean, SD) 0.22 0.067
All had retinopathy and negative urine microscopy for red cell casts.
profile, section level within the glomerulus, or the glomerular
orientation when viewed.
The low power (X2,000) montages were used for the estimation
of mesangial volume density relative to the glomerular tuft. A
regular grid consisting of a tessellation of 8 fine points per coarse
point was laid in random fashion upon the montage. Coarse points
landing on the tuft, defined as capillaries and mesangium con-
tained within a minimal string polygon, were counted (CP) [61.
Fine points landing on mesangium, consisting of mesangial ma-
trix, mesangial basement membrane-like material and mesangial
cellular components were also counted (FP).
Mesangial volume fraction was estimated as:
V, mes/tuft = FP mesangium/CP tuft >< 8.
On the higher magnification (x10,000) micrographs, tuft and
mesangium were defined the same way, but a different grid of 4
fine to 1 coarse point was used. The matrix fraction included any
peripheral glomerular basement membrane like material located
at the mesangio-urinary and capillary interfaces, but excluded any
cellular components.
Matrix volume fraction was estimated as:
V matrix/tuft = FP matrix/CP tuft >< 4.
Statistical analysis
An exploratory approach to the analysis was adopted. The
results from counts at each section level within individual glomer-
uli were used to derive estimates for V mesangium and V
matrix. As the mean counts within a level were 85 for mesangium
and 246 for matrix, with 75% of mesangial counts being over 40
and 90% of matrix counts being over 48, the measurement error
was not considered to be unduly large [14]. The "adjacent" levels
were sufficiently separated (50 jim) to be regarded as spatially
independent within the same glomerulus. In order to examine the
contributions of patients, glomeruli and levels, a variance compo-
nents analysis was performed using the method of restricted
maximum likelihood (REML) applied to a nested random model
[15]. The total variability in the data is broken down into its
individual components: the variability between patients r2, be-
tween glomeruli within patients ag2 and between levels within
glomeruli a12. The results from the variance components analysis
were used to assess the precision which might be associated with
alternative sampling schemes and with estimates of within patient
changes over time or in response to treatment. For example, if ng
glomeruli are sampled from each patient with n1 levels examined
in each glomerulus, then the variation observed between the mean




The SD is the square root of this estimation. The assumption that
there is no systematic effect for level was examined by visual
inspection of the data and by using a fixed effect analysis of
variance.
Results
A statistically significant relationship between volume fraction
of mesangium and log albumin excretion rate was found (r2 =
0.43; P = 0.038). No non-diabetic glomerular changes were seen
on microscopy. For three patients, all glomeruli had three levels;
three patients had two glomeruli with four levels and one with
three levels; three patients had four levels in each glomerulus and
one patient had two glomeruli with four levels and one with five.
The overall mean mesangial V and matrix V using all sections
are given in Table 1. The contribution of the various constituents
to the overall between-patient means variance for a scheme using
three glomeruli each with three levels is given in Table 2.
To assess the validity of assuming random differences between
levels within the glomerulus, the fixed effect analysis of variance
was performed on both the complete data (3 to 5 levels per
glomerulus) and on the first three levels per glomerulus that were
available for all glomeruli, regardless of size. The first section and
third section of three levels, fourth section of four levels, or fifth
of five levels lie peripheral to the glomerulus and have been
termed "extreme." There was no evidence to suggest that there
were systematic differences between levels, but the extreme levels
within a glomerulus tended to have either a relatively high or low
value. The range of points counted on mesangial and matrix areas
in these extreme sections was 0 to 124 and 0 to 199, respectively,
compared to 42 to 285 and 123 to 780 on remaining non-extreme
sections. This suggests that the estimates of mesangium obtained
from extreme levels that had smaller areas could bias the overall
glomerular estimate of mesangial V (Fig. 1).
The results from this analysis have been used to assess the
precision of alternative sampling schemes. If one non-extreme
level is used, from each of three glomeruli, such as level two,
which is 50 to 99 jim from the edge of the glomerulus, then the
between patient mean SD is estimated to be 0.105 and 0.071 for
mesangial and matrix volume fractions, respectively. These values
may be compared with the SDS of 0.108 and 0.067 shown in Table
1 obtained from analysis of three or more levels from three
glomeruli. Using one level but increasing the number of glomeruli
sampled to six reduced the SD of V. mesangium and matrix by less
than 5%.
In order to explore changes in glomerular structure between
baseline and follow-up biopsies, results from the components of
variance analysis may be used to derive an estimate for the SD of
the difference in mesangial and matrix Vv. Because the analysis of
interest is a "within patient" change over time, the between
patient component of variance can be omitted. The remaining
variance is then doubled (as there are 2 measurements) and an
estimate of SD of the difference can be obtained by taking its
square root. Table 3 shows the estimated SD of the mean
differences in mesangial V using one non-extreme level in three
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Fig. 1. Schematic drawing of a glomerulus (left) sampled by four equally spaced sections at 50 fUn intervals with representative cross sections at two levels
shown on the right. Note the potential variation in sampling of mesangial areas (in black) at level 2 (central) versus level 4 (extreme). [Adapted from
JUNQuEIRA LC, CARNEIRO J: Basic Histology (3rd ed). Los Altos, Lange Medical Publications, 1980, p 395.]
Table 2. Contributions of between patient, between glomeruli and
between level variability to overall patient mean variability of mesangial








Mesangial V,,, 88 0 12
Matrix V,. 84 4
—_______
12
See text for detailed formula. Total variability is broken down into its
components between patients, glomeruli and levels. Note that most
variance is between patients, with a small component between levels and
virtually none between glomeruli.
to six glomeruli. There appeared to be only a modest reduction in
estimated SD of differences in mesangial V., if more than five
glomeruli were sampled.
The time taken by the various stages in the processing of each
biopsy were averaged and arc shown in Table 4. Single level
sampling of three glomeruli was completed in approximately 45%
of the time taken by the multiple level regimen. Even if five
glomeruli were sectioned at one level, the total time taken to
process one biopsy was 80 hours, still representing a saving of 23%
over the multiple level method.
Discussion
Although this report does not set out to explore glomerular
structural-functional relationships, it is of note that even with this
small number of patients, a significant relationship between
Table 3. Estimated standard deviation (SI)) of differences from baseline
for follow-up biopsies as derived from component of variance analysis
No. of glomeruli sampled 3 4 5 6
Mesangial Vs,, 0.062 0.054 0.048 0.044
Matrix V., 0.043 0.037 0.034 0.031
The progressive reduction in so is a consequence of the increasing
precision of the estimate with an increasing sample size. Note that there is
minimal improvement in the so of the estimate when increasing the
number of glomeruli sampled from 5 to 6.
mesangial volume fraction and albumin excretion was found. This
result is consistent with previous reports [5, 6] and suggests that
our sample is a valid representation of IDDM patients with
nephropathy.
Although morphometric evaluation of the glomerular mesan-
guil changes in diabetes has tended to be limited to specialist
centers, the techniques used are straightforward and could be
developed in any electron microscopy laboratory offering a clinical
service [10, 161. If such examination is to he useful, a sensitive yet
efficient method of analysis of mesangial volume is needed. Our
results suggest that non-extreme, single level sampling of three
glomeruli per biopsy entails no loss of precision in the estimate of
fl)eSangial and matrix volume fractions compared to the more
laborious multiple level method. The components of variance
analysis indicated that the differences between individual patients
are by far the most important source of variability of the estimate.
Interestingly, it also demonstrated remarkably little difference in
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Table 4. Processing time (hours) at each stage in the analysis of renal
biopsy specimens depending on analytical method
Method Sectioning Photography Measurement Total
Multiple levels, 31 42 31 104
3 glomeruli
Single level, 15 20 15 50
3 glomeruli
Single level, 24 32 24 80
5_glomeruli _______________ _____________
mesangial volume between glomeruli within an individual patient,
suggesting a uniformity of severity of glomerulopathy.
Light microscopic, descriptive, cross sectional studies in dia-
betic patients have led to the belief that glomerulopathy in an
individual affects glomeruli to different degrees, and is sometimes
described as patchy. This misconception is almost certainly a
reflection of sampling bias. Our data, and those of others, show
that careful analysis of individual glomeruli reveal similar degrees
of mesangial expansion within a given patient, and that these
changes are similar in cortical and juxtamedullary glomeruli [17].
The extreme outermost levels were subject to greater estima-
tion error. Inclusion of such sections may partly explain the
observed variability in estimates found in previous studies [5—7,
181. Human diabetic glomeruli tend to be large [19, 201, so by
examining sections taken 50 to 99 jim into the glomerulus, the
requirements for random sampling are fulfilled [18] without the
potential problems inherent in sampling the peripheral regions.
The differences in V. mesangium between open glomeruli in an
individual patient contributed less than 5% of the total variability,
thus there are very small gains to he made in precision of the
estimate by examining more than three glomeruli in cross-
sectional studies designed to assess between patient differences.
However, from our data, we estimate that greater relative gains in
the detection of differences within patients, whether with time or
in response to therapeutic intervention, may be made by increas-
ing the number of glomeruli examined. These estimates should be
interpreted with caution, however, as the omission of the between
patient effect may lead to an underestimation of the SD of
differences. Despite this, sampling more than five glomeruli would
seem to result in a negligible improvement in precision of < 10%
of the estimated SD.
It is beyond the scope of this paper to discuss the detailed
power calculations that must be made prior to embarking on an
intervention study using glomerular structural end points. Neither
can we predict at this stage which structural parameters will
require what degree of precision in their estimates in order to
detect any change following therapeutic intervention. It is clear
however, that mesangial volume is one of the most consistent
structural measures that relates to glomerular function and albu-
minuria [5, 6], and it is partly because of this that the present
analysis was undertaken. Only at the end of our study will it be
possible to determine whether the projected degree of precision
will be adequate to detect a treatment effect, and whether our
study period of three years is of sufficient duration. The results
generated from the placebo treated patients should provide
valuable information upon which to estimate the statistical power
of future studies.
The savings made in the time required to process one biopsy
from arrival in the laboratory are substantial if the number of
levels examined is reduced to one per glomerulus. Certainly, less
use is made of the electron microscope, photographic consum-
ables are reduced and a greater number of biopsies may be
processed for a given length of research staff time. Increasing the
number of glomeruli examined per biopsy to five still results in a
significant time saving compared to the multiple sectioning re-
gime. It is possible that future developments in image projection
using high resolution video may lead to a situation where photog-
raphy and montage construction is no longer necessary. Such a
development would, of course, reduce processing time still fur-
ther. However, our present system cannot capture an entire
glomerular profile on one projection, particularly as diabetic
glomeruli tend to be so large, and we have no option but to
continue to work from photographs. In addition, newer methods
of image analysis may bring their own problems and possibly
introduce a measurement bias. The stereological maxim of "Do
more, less well" remains an important guiding principle [14].
Our analysis relates to biopsies taken from patients with
abnormal albumin excretion but normal blood pressures and
relatively well-preserved renal function. In these patients the
observed structural changes of diabetic nephropathy were well
established with V, mesangium above the non-diabetic range and
confluent areas of matrix seen on electron microscopy. In patients
with V mesangium within or near the normal range, the number
of points counted on both component and reference space may
need to be increased [14, 16]. Provided that this consideration is
taken into account, single level sampling would almost certainly
provide an efficient and precise method of analyzing biopsies
taken at an earlier stage in diabetic nephropathy.
In view of our findings, the protocol for handling biopsies in our
laboratory has been amended to sampling three glomeruli per
biopsy, at a single level between 50 and 99 jim into the glomer-
ulus. This provides a more efficient method of analysis without
sacrificing precision. For follow-up studies we are sampling five
glomeruli on the basis of our estimated SD of differences. Confir-
mation of this approach will need to await analysis of the
three-year repeat biopsies in our study.
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